Clinical relevance of circulating cell-free microRNAs in cancer
H Schwarzenbach, N Nishida, GA Calin… - Nature reviews Clinical …, 2014 - nature.com
Efficient patient management relies on early diagnosis of disease and monitoring of
treatment. In this regard, much effort has been made to find informative, blood-based …
treatment. In this regard, much effort has been made to find informative, blood-based …
Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy
G Cheng - Advanced drug delivery reviews, 2015 - Elsevier
MicroRNAs (miRNAs) belong to a class of small non-coding RNAs that regulate numerous
biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have …
biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have …
Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers
HH Wu, W Lin, KW Tsai - Expert reviews in molecular medicine, 2014 - cambridge.org
Carcinoma of the stomach is one of the most prevalent cancer types in the world. Although
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …
DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer
Cancer initiation and progression is controlled by both genetic and epigenetic events.
Epigenetics refers to the study of mechanisms that alter gene expression without …
Epigenetics refers to the study of mechanisms that alter gene expression without …
[HTML][HTML] Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: an update and review
YK Huang, JC Yu - World journal of gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Gastric cancer (GC) is the fourth most common cancer and the third leading cause of cancer
mortality worldwide. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are the …
mortality worldwide. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are the …
Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: current status and future perspectives
H Mirzaei, S Khataminfar… - Current medicinal …, 2016 - ingentaconnect.com
Gastric cancer is among the leading causes of cancer related death worldwide. Patients with
gastric cancer are typically asymptomatic, and diagnosed at late stages, supporting the need …
gastric cancer are typically asymptomatic, and diagnosed at late stages, supporting the need …
[HTML][HTML] MicroRNAs in cancer biology and therapy: current status and perspectives
C Price, J Chen - Genes & diseases, 2014 - Elsevier
The study of a class of small non-coding RNA molecules, named microRNAs (miRNAs), has
advanced our understanding of many of the fundamental processes of cancer biology and …
advanced our understanding of many of the fundamental processes of cancer biology and …
[HTML][HTML] Recent advances in the molecular diagnostics of gastric cancer
M Kanda, Y Kodera - World Journal of Gastroenterology: WJG, 2015 - ncbi.nlm.nih.gov
Gastric cancer (GC) is the third most common cause of cancer-related death in the world,
representing a major global health issue. Although the incidence of GC is declining, the …
representing a major global health issue. Although the incidence of GC is declining, the …
MicroRNAs‐based imaging techniques in cancer diagnosis and therapy
M Keshavarzi, S Sorayayi… - Journal of cellular …, 2017 - Wiley Online Library
Cancer is one of the most serious global health concerns in different populations. Several
studies indicated that there are many potentially promising cellular and molecular targets for …
studies indicated that there are many potentially promising cellular and molecular targets for …
[HTML][HTML] MicroRNAs as potential biomarkers for gastric cancer
HS Liu, HS Xiao - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Gastric cancer is the fourth most common cancer in the world and the second leading cause
of cancer-related death. More than 80% of diagnoses occur at the middle to late stage of the …
of cancer-related death. More than 80% of diagnoses occur at the middle to late stage of the …